Foghorn Therapeutics Inc. (FHTX) › Operating IncomeFoghorn Therapeutics Inc. (FHTX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$51.08M2020: -$68.53M2021: -$100.73M2022: -$117.14M2023: -$107.91M2024: -$102.68M2025: -$86.39M-$86.39M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$86.39M+15.9%2024-$102.68M+4.8%2023-$107.91M+7.9%2022-$117.14M-16.3%2021-$100.73M-47.0%2020-$68.53M-34.2%2019-$51.08M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share